These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 11744708

  • 1. Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli.
    Mysorekar IU, Mulvey MA, Hultgren SJ, Gordon JI.
    J Biol Chem; 2002 Mar 01; 277(9):7412-9. PubMed ID: 11744708
    [Abstract] [Full Text] [Related]

  • 2. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding.
    Zhou G, Mo WJ, Sebbel P, Min G, Neubert TA, Glockshuber R, Wu XR, Sun TT, Kong XP.
    J Cell Sci; 2001 Nov 01; 114(Pt 22):4095-103. PubMed ID: 11739641
    [Abstract] [Full Text] [Related]

  • 3. Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis.
    Klumpp DJ, Rycyk MT, Chen MC, Thumbikat P, Sengupta S, Schaeffer AJ.
    Infect Immun; 2006 Sep 01; 74(9):5106-13. PubMed ID: 16926402
    [Abstract] [Full Text] [Related]

  • 4. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.
    Eto DS, Jones TA, Sundsbak JL, Mulvey MA.
    PLoS Pathog; 2007 Jul 01; 3(7):e100. PubMed ID: 17630833
    [Abstract] [Full Text] [Related]

  • 5. Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract.
    Kurimura Y, Nishitani C, Ariki S, Saito A, Hasegawa Y, Takahashi M, Hashimoto J, Takahashi S, Tsukamoto T, Kuroki Y.
    J Biol Chem; 2012 Nov 16; 287(47):39578-88. PubMed ID: 23012359
    [Abstract] [Full Text] [Related]

  • 6. Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract.
    Rosen DA, Pinkner JS, Walker JN, Elam JS, Jones JM, Hultgren SJ.
    Infect Immun; 2008 Jul 16; 76(7):3346-56. PubMed ID: 18474655
    [Abstract] [Full Text] [Related]

  • 7. Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli.
    Liu Y, Mémet S, Saban R, Kong X, Aprikian P, Sokurenko E, Sun TT, Wu XR.
    Sci Rep; 2015 Nov 09; 5():16234. PubMed ID: 26549759
    [Abstract] [Full Text] [Related]

  • 8. Bacteria-induced uroplakin signaling mediates bladder response to infection.
    Thumbikat P, Berry RE, Zhou G, Billips BK, Yaggie RE, Zaichuk T, Sun TT, Schaeffer AJ, Klumpp DJ.
    PLoS Pathog; 2009 May 09; 5(5):e1000415. PubMed ID: 19412341
    [Abstract] [Full Text] [Related]

  • 9. Localization of uroplakin Ia, the urothelial receptor for bacterial adhesin FimH, on the six inner domains of the 16 nm urothelial plaque particle.
    Min G, Stolz M, Zhou G, Liang F, Sebbel P, Stoffler D, Glockshuber R, Sun TT, Aebi U, Kong XP.
    J Mol Biol; 2002 Apr 12; 317(5):697-706. PubMed ID: 11955018
    [Abstract] [Full Text] [Related]

  • 10. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
    Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, Hultgren SJ.
    Science; 1998 Nov 20; 282(5393):1494-7. PubMed ID: 9822381
    [Abstract] [Full Text] [Related]

  • 11. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
    Schilling JD, Mulvey MA, Vincent CD, Lorenz RG, Hultgren SJ.
    J Immunol; 2001 Jan 15; 166(2):1148-55. PubMed ID: 11145696
    [Abstract] [Full Text] [Related]

  • 12. Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli.
    Berry RE, Klumpp DJ, Schaeffer AJ.
    Infect Immun; 2009 Jul 15; 77(7):2762-72. PubMed ID: 19451249
    [Abstract] [Full Text] [Related]

  • 13. A non-canonical autophagy-dependent role of the ATG16L1T300A variant in urothelial vesicular trafficking and uropathogenic Escherichia coli persistence.
    Wang C, Bauckman KA, Ross ASB, Symington JW, Ligon MM, Scholtes G, Kumar A, Chang HW, Twentyman J, Fashemi BE, Xavier RJ, Mysorekar IU.
    Autophagy; 2019 Mar 15; 15(3):527-542. PubMed ID: 30335568
    [Abstract] [Full Text] [Related]

  • 14. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    Thankavel K, Madison B, Ikeda T, Malaviya R, Shah AH, Arumugam PM, Abraham SN.
    J Clin Invest; 1997 Sep 01; 100(5):1123-36. PubMed ID: 9276729
    [Abstract] [Full Text] [Related]

  • 15. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M, Asadi Karam MR, Shokrgozar MA, Oloomi M, Jafari A, Bouzari S.
    Mol Immunol; 2015 Apr 01; 64(2):285-94. PubMed ID: 25562574
    [Abstract] [Full Text] [Related]

  • 16. Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli.
    Martinez JJ, Hultgren SJ.
    Cell Microbiol; 2002 Jan 01; 4(1):19-28. PubMed ID: 11856170
    [Abstract] [Full Text] [Related]

  • 17. Glycosylation changes as important factors for the susceptibility to urinary tract infection.
    Taganna J, de Boer AR, Wuhrer M, Bouckaert J.
    Biochem Soc Trans; 2011 Jan 01; 39(1):349-54. PubMed ID: 21265802
    [Abstract] [Full Text] [Related]

  • 18. Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli.
    Thumbikat P, Berry RE, Schaeffer AJ, Klumpp DJ.
    Microbes Infect; 2009 Jan 01; 11(1):57-65. PubMed ID: 19007907
    [Abstract] [Full Text] [Related]

  • 19. Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.
    Lin AE, Beasley FC, Olson J, Keller N, Shalwitz RA, Hannan TJ, Hultgren SJ, Nizet V.
    PLoS Pathog; 2015 Apr 01; 11(4):e1004818. PubMed ID: 25927232
    [Abstract] [Full Text] [Related]

  • 20. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling.
    Ashkar AA, Mossman KL, Coombes BK, Gyles CL, Mackenzie R.
    PLoS Pathog; 2008 Dec 01; 4(12):e1000233. PubMed ID: 19057665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.